Stifel Nicolaus Trims WELL Health Technologies (TSE:WELL) Target Price to C$10.00

WELL Health Technologies (TSE:WELL) had its target price decreased by Stifel Nicolaus from C$11.00 to C$10.00 in a research report report published on Monday, BayStreet.CA reports.

WELL has been the topic of several other research reports. Pi Financial raised their target price on WELL Health Technologies from C$8.25 to C$8.50 in a research report on Wednesday, January 31st. Royal Bank of Canada set a C$5.50 price objective on shares of WELL Health Technologies and gave the stock an outperform rating in a research report on Tuesday, February 6th. Finally, CIBC cut shares of WELL Health Technologies from an outperform rating to a neutral rating and lowered their target price for the company from C$5.50 to C$4.75 in a report on Monday, January 22nd. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of Moderate Buy and an average price target of C$7.13.

WELL Health Technologies Stock Performance

TSE:WELL opened at C$3.60 on Monday. The firm has a market capitalization of C$884.27 million, a PE ratio of -185.00, a price-to-earnings-growth ratio of -1.93 and a beta of 1.27. The company has a debt-to-equity ratio of 50.38, a current ratio of 1.15 and a quick ratio of 1.02. The business’s fifty day moving average price is C$3.78 and its 200 day moving average price is C$3.85. WELL Health Technologies has a 12 month low of C$3.41 and a 12 month high of C$5.94.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.